Results 291 to 300 of about 56,186 (320)

Trends in kinase drug discovery: targets, indications and inhibitor design

Nature Reviews Drug Discovery, 2021
Misty M Attwood, Stefan Knapp
exaly  

Aromatase inhibitors

Menopause, 2007
openaire   +2 more sources

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

Second-Generation Aromatase Inhibitors

Tumori Journal, 1995
E, Bajetta, N, Zilembo, C, Noberasco
openaire   +2 more sources

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

Novel Irreversible Aromatase Inhibitors

Annals of the New York Academy of Sciences, 1990
E, di Salle, D, Giudici, G, Briatico, G, Ornati   +3 more
openaire   +2 more sources

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Aromatase Inhibitors

2009
Paul E. Goss, Caroline C. Reid
openaire   +1 more source

RAS-targeted therapies: is the undruggable drugged?

Nature Reviews Drug Discovery, 2020
Amanda R Moore, Frank McCormick, Shiva Malek   +2 more
exaly  

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cell, 2020
Markus Hoffmann, Nadine Krüger, Tobias S Schiergens   +2 more
exaly